Infertility. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF

By Fujii Shunsaku   Sato Shigemi   Fukui Atsushi   Kimura Hidetaka   Kasai Goichiro  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1671-1675

Oxford University Press

Access to resources Recommend Favorite

Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist/follicle stimulating hormone ovulation induction for in-vitro fertilization

By Lass A  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3203-3205

Oxford University Press

Access to resources Recommend Favorite

Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos

By Rekha P   Mowat L   Jamieson ME   Yates RWS   Fleming R  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 696-698

Oxford University Press

Access to resources Recommend Favorite

Children. Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy

By Lahat E.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2656-2660

Oxford University Press

Access to resources Recommend Favorite

Infertility. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist–gonadotrophin treatment

By Peñarrubia Joana  

Human Reproduction, Vol. 15, Iss. 7, 2000-07 ,pp. : 1499-1504

Oxford University Press

Access to resources Recommend Favorite